Coriolis is the leading independent contract research organization dedicated on formulation development of biopharmaceuticals. We transform our customer’s vision on new molecules into successful products from first-in–human to commercial.”
Coriolis competence is integrated into 3 different business units for liquid formulation including high concentration, lyophilization development and analytical services under R&D and GMP. Our customers are big pharma as well as midsize and small biotech companies, from all over the world (equally spread between the US and EU about 15% are located in Asia).
[ Ссылка ]
